|
|
|
Volumn 49, Issue 5, 2003, Pages 484-490
|
|
Hemorheological and clinical efficiency of new phospholipid hepatoprotective drug "Phosphogliv" in patients with psoriatic arthritis
a
|
|
Author keywords
Blood viscosity; Erythrocytes aggregation; Phospholipids; Psoriatic arthritis
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
C REACTIVE PROTEIN;
IMMUNOMODULATING AGENT;
LIVER PROTECTIVE AGENT;
PHOSPHOGLIV;
PHOSPHOLIPID DERIVATIVE;
UNCLASSIFIED DRUG;
GLYCYRRHIZIC ACID;
PHOSPHATIDYLCHOLINE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BLOOD RHEOLOGY;
BLOOD VISCOSITY;
COMORBIDITY;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG MECHANISM;
ERYTHROCYTE AGGREGATION;
ERYTHROCYTE MEMBRANE;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
LIVER CELL MEMBRANE;
LIVER DISEASE;
LIVER PROTECTION;
PROTEIN BLOOD LEVEL;
PSORIATIC ARTHRITIS;
STATISTICAL SIGNIFICANCE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
BLOOD;
CLINICAL TRIAL;
DRUG COMBINATION;
ARTHRITIS, PSORIATIC;
BLOOD VISCOSITY;
DRUG COMBINATIONS;
ERYTHROCYTE AGGREGATION;
GLYCYRRHIZIC ACID;
HEMORHEOLOGY;
HUMANS;
PHOSPHATIDYLCHOLINES;
|
|
EID: 0347623026
PISSN: 23106905
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (18)
|
